Susquehanna International Group
ZBIO

Susquehanna International Group’s Zenas BioPharma ZBIO Stock Holding History

Susquehanna International Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Buy
58,100
+51,000
+718% +$1.14M ﹤0.01% 7553
2025
Q4 		$258K Buy
+7,100
New +$234K ﹤0.01% 10302

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Susquehanna International Group's ZBIO Position: Q1 2026 in Review

Susquehanna International Group increased its Zenas BioPharma (ZBIO) stake by 521% in Q1 2026, buying an estimated $1.6M and bringing the position to 85,005 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #6600.

Susquehanna International Group first reported a position in ZBIO in Q1 2025 and has held it in 4 quarters since. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Susquehanna International Group held 85,005 shares of Zenas BioPharma worth $1.66M as of Q1 2026.
  • Susquehanna International Group bought 71,327 Zenas BioPharma shares in Q1 2026, an estimated $1.6M.
  • Zenas BioPharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6600 holding.
  • Susquehanna International Group first reported a position in Zenas BioPharma in Q1 2025 and has held it in 4 quarters since.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.